Miilera Pharmaceuticals Private Limited
About Miilera Pharmaceuticals Private Limited
Data last updated:
Miilera Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 07 August 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24304TG2019PTC134672. Its GSTIN is 36AAMCM8647E1Z2 (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Harish Ramesh Tirmanwar and Priyanka Gonepally.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 709 Block 2 Smr Vinay Harmony Bandlaguda Jagir Rajendra Nagar, Hyderabad, Telangana, India – 500093.
As per the financials filed for FY 2025, the company reported a revenue of ₹98.08 Lakh, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹1.72 Lakh (net margin 1.8%) and EBITDA of ₹2.49 Lakh (EBITDA margin 2.5%). Revenue has grown at a compounded annual rate (CAGR) of 81% over three years.
Company details
Contact details
Miilera Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressFlat No. 709 Block 2 Smr Vinay Harmony Bandlaguda Jagir Rajendra Nagar, Hyderabad, Telangana, India – 500093
- IndustryFood And Beverages, Manufacturing, Artificial Fibres
To see the full contact details of Miilera Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Miilera Pharmaceuticals is information and communication. In detail, this covers computer programming, consultancy and related activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| J | Information and communication | J6 | Computer programming, consultancy and related activities |
To see the full business activity and turnover split of Miilera Pharmaceuticals Private Limited, buy the company report.
Financials of Miilera Pharmaceuticals Private Limited
FY 2025 filings availableMiilera Pharmaceuticals Private Limited reported revenue of ₹98.08 Lakh (up 20% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 81% over three years, including 20% growth in the latest year. EBITDA fell 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.49 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.72 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.5% | ||||
| Net Profit Margin | 1.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Miilera Pharmaceuticals Private Limited, buy the company report.
Board of directors of Miilera Pharmaceuticals Private Limited
Miilera Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harish Ramesh Tirmanwar | Director | 19 Dec 2020 | 5 Years 10 Months | Current |
| Priyanka Gonepally | Director | 18 Sep 2025 | 1 Years 1 Months | Current |
Legal cases
No court or tribunal cases involving Miilera Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Miilera Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Miilera Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAMCM8647E1Z2 | Telangana | Active | 03 May 2021 |
To see the full GST registrations and return filing status of Miilera Pharmaceuticals Private Limited, buy the company report.
Recent activity
Miilera Pharmaceuticals Private Limited has 7 board changes on record since 2020: 3 appointments and 4 cessations. The latest: Priyanka Gonepally was appointed as Director on 18 Sep 2025.
Frequently asked questions
Miilera Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 07 August 2019 (7+ years old) and is registered under CIN U24304TG2019PTC134672.
Miilera Pharmaceuticals has 2 current directors:
- Harish Ramesh Tirmanwar - Director
- Priyanka Gonepally - Director
The latest financial statements of Miilera Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Miilera Pharmaceuticals is 36AAMCM8647E1Z2, registered in Telangana.
The CIN (Corporate Identification Number) of Miilera Pharmaceuticals is U24304TG2019PTC134672. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Miilera Pharmaceuticals was incorporated on 07 August 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
Priyanka Gonepally was appointed as Director on 18 Sep 2025. Pruthviraj Rajesh Mamidwar ceased to be Director on 18 Sep 2025. Archana Dravadi ceased to be Director on 30 Oct 2022. Miilera Pharmaceuticals has 7 board changes on record in total.
The registered office of Miilera Pharmaceuticals is at Flat No. 709 Block 2 Smr Vinay Harmony Bandlaguda Jagir Rajendra Nagar, Hyderabad, Telangana, India – 500093.
Miilera Pharmaceuticals operates in the food and beverages industry, in the manufacturing segment.
Miilera Pharmaceuticals can be reached at its registered office: Flat No. 709 Block 2 Smr Vinay Harmony Bandlaguda Jagir Rajendra Nagar, Hyderabad, Telangana, India – 500093.